logo
Plus   Neg
Share
Email

Myriad Genetics Inc. Q4 adjusted earnings of $0.41 per share

Below are the earnings highlights for Myriad Genetics Inc. (MYGN):

-Earnings: -$4.2 million in Q4 vs. $14.5 million in the same period last year.
-EPS: -$0.06 in Q4 vs. $0.20 in the same period last year.
-Excluding items, Myriad Genetics Inc. reported adjusted earnings of $30.7 million or $0.41 per share for the period.
-Revenue: $215.4 million in Q4 vs. $193.9 million in the same period last year.

For comments and feedback contact: editorial@rttnews.com

Follow RTT
>